Study S003357

A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of ZT002 Injection in Subjects With Overweight or Obesity

ClinicalTrials.gov record

Registration

Registration: NCT07020884
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: COMPLETED
Enrollment: 303
Start: 2024-08-14
Primary completion: 2025-05-07
Lead sponsor: Beijing QL Biopharmaceutical Co.,Ltd
Conditions: Overweight or Obesity
Interventions: DRUG:ZT002 Injection; DRUG:ZT002 Placebo
Results posted: FALSE

Registered primary outcomes

The percentage change from baseline in weight after 24 weeks of treatment. [baseline, 24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.